But figuring out which one fits your needs best
Gastrointestinal adverse events occurred in 79.6% of CagriSema participants versus 39.9% with placebo, were mostly transient, and led to discontinuation in 6-8.4% of participants
Three main mechanisms drive this: Metabolic adaptation : As you lose weight, your resting metabolic rate drops
This is an important proposition for the modernisation and industrialisation of TMMM (Li, 2019)
-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects In Vitro and In Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
31:1058-69 33MARTIN K, WIESNER G, BREUER T, et al